Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Xylitol Based Nasal Spray for the Treatment of Mild COVID-19 Infection

NCT05618483 is registered in ClinicalTrials.gov with Xlear, Inc as lead sponsor.

NCT NCT05618483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05618483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Xylitol Based Nasal Spray for the Treatment of Mild COVID-19 Infection
Lead sponsor
Xlear, Inc
Phase
Not applicable
Overall status
Unknown status
Start date
November 28, 2022
Completion date
June 30, 2024
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory viral infection